Cargando…

Therapeutic Use of Dendritic Cells to Promote the Extranodal Priming of Anti-Tumor Immunity

Ectopic lymphoid tissue, also known as tertiary lymphoid organs (TLO) develop adaptively within sites of chronic tissue inflammation, thereby allowing the host to efficiently crossprime specific immune effector cells within sites of disease. Recent evidence suggests that the presence of TLO in the t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Lu, Fabian, Kellsye L., Taylor, Jennifer L., Storkus, Walter J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2013
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3843121/ https://www.ncbi.nlm.nih.gov/pubmed/24348473 http://dx.doi.org/10.3389/fimmu.2013.00388

Ejemplares similares

Extranodal induction of therapeutic immunity in the tumor microenvironment after intratumoral delivery of Tbet gene-modified dendritic cells
por: Chen, Lu, et al.
Publicado: (2013)

STINGing the Tumor Microenvironment to Promote Therapeutic Tertiary Lymphoid Structure Development
por: Filderman, Jessica N., et al.
Publicado: (2021)

Editorial: Dendritic cell-primed T cells in anti-tumor immune responses and relevant vaccine strategies
por: Leavenworth, Jianmei W., et al.
Publicado: (2022)

Tipping the scales: Immunotherapeutic strategies that disrupt immunosuppression and promote immune activation
por: Santiago-Sánchez, Ginette S., et al.
Publicado: (2022)

STING agonist-based treatment promotes vascular normalization and tertiary lymphoid structure formation in the therapeutic melanoma microenvironment
por: Chelvanambi, Manoj, et al.
Publicado: (2021)

Immune Modulation Plus Tumor Ablation: Adjuvants and Antibodies to Prime and Boost Anti-Tumor Immunity In Situ
por: van den Bijgaart, Renske J. E., et al.
Publicado: (2021)

Thymoproteasome-Expressing Mesenchymal Stromal Cells Confer Protective Anti-Tumor Immunity via Cross-Priming of Endogenous Dendritic Cells
por: Bikorimana, Jean-Pierre, et al.
Publicado: (2021)

Therapeutic effectiveness of intratumorally-delivered dendritic cells engineered to express the pro-inflammatory cytokine, interleukin (IL)-32
por: Qu, Yanyan, et al.
Publicado: (2011)

Tumor-Altered Dendritic Cell Function: Implications for Anti-Tumor Immunity
por: Hargadon, Kristian M.
Publicado: (2013)

Dasatinib promotes the expansion of a therapeutically superior T-cell repertoire in response to dendritic cell vaccination against melanoma
por: Lowe, Devin B, et al.
Publicado: (2014)

Wnt Signaling Cascade in Dendritic Cells and Regulation of Anti-tumor Immunity
por: Suryawanshi, Amol, et al.
Publicado: (2020)

Tumor Arrests DN2 to DN3 Pro T Cell Transition and Promotes Its Conversion to Thymic Dendritic Cells by Reciprocally Regulating Notch1 and Ikaros Signaling
por: Guha, Ipsita, et al.
Publicado: (2020)

The Role of Tumor/Dendritic Cell Interactions in the Regulation of Anti-Tumor Immunity: The Good, the Bad, and the Ugly
por: Hargadon, Kristian Michael, et al.
Publicado: (2014)

Glycan modification of antigen alters its intracellular routing in dendritic cells, promoting priming of T cells
por: Streng-Ouwehand, Ingeborg, et al.
Publicado: (2016)

Neutralizing TGF-β promotes anti-tumor immunity of dendritic cells against pancreatic cancer by regulating T lymphocytes
por: Pu, Ning, et al.
Publicado: (2018)

TLR3 Activation of Intratumoral CD103(+) Dendritic Cells Modifies the Tumor Infiltrate Conferring Anti-tumor Immunity
por: Roselli, Emiliano, et al.
Publicado: (2019)

Ovarian Cancer-Intrinsic Fatty Acid Synthase Prevents Anti-tumor Immunity by Disrupting Tumor-Infiltrating Dendritic Cells
por: Jiang, Li, et al.
Publicado: (2018)

The Natural Killer–Dendritic Cell Immune Axis in Anti-Cancer Immunity and Immunotherapy
por: Peterson, Erin E., et al.
Publicado: (2021)

Staphylococcus aureus PSM Peptides Modulate Human Monocyte-Derived Dendritic Cells to Prime Regulatory T Cells
por: Richardson, Jennifer R., et al.
Publicado: (2018)

Biosynthesis and Functional Significance of Peripheral Node Addressin in Cancer-Associated TLO
por: Weinstein, Aliyah M., et al.
Publicado: (2016)

Inhibition of Human Dendritic Cell ER Stress Response Reduces T Cell Alloreactivity Yet Spares Donor Anti-tumor Immunity
por: Betts, Brian C., et al.
Publicado: (2018)

Dendritic Cells and CD8 T Cell Immunity in Tumor Microenvironment
por: Fu, Chunmei, et al.
Publicado: (2018)

Role of Tumor-Mediated Dendritic Cell Tolerization in Immune Evasion
por: DeVito, Nicholas C., et al.
Publicado: (2019)

Genealogy, Dendritic Cell Priming, and Differentiation of Tissue-Resident Memory CD8(+) T Cells
por: Enamorado, Michel, et al.
Publicado: (2018)

Dendritic cell expression of CD24 contributes to optimal priming of T lymphocytes in lymph nodes
por: Zhang, Xuejun, et al.
Publicado: (2023)

Type I Interferons as Stimulators of DC-Mediated Cross-Priming: Impact on Anti-Tumor Response
por: Schiavoni, Giovanna, et al.
Publicado: (2013)

Shp1 Loss Enhances Macrophage Effector Function and Promotes Anti-Tumor Immunity
por: Myers, Darienne R., et al.
Publicado: (2020)

Heterologous Prime-Boost Combinations Highlight the Crucial Role of Adjuvant in Priming the Immune System
por: Ciabattini, Annalisa, et al.
Publicado: (2018)

The Therapeutic Potential of Tackling Tumor-Induced Dendritic Cell Dysfunction in Colorectal Cancer
por: Subtil, Beatriz, et al.
Publicado: (2021)

Treatment of extranodal NK/T-cell lymphoma: From past to future
por: Yan, Zheng, et al.
Publicado: (2023)

Dendritic Cell-Targeted Approaches to Modulate Immune Dysfunction in the Tumor Microenvironment
por: Gallois, Anne, et al.
Publicado: (2013)

Allergen Recognition by Innate Immune Cells: Critical Role of Dendritic and Epithelial Cells
por: Salazar, Fabián, et al.
Publicado: (2013)

Purinergic receptors are a key bottleneck in tumor metabolic reprogramming: The prime suspect in cancer therapeutic resistance
por: Aria, Hamid, et al.
Publicado: (2022)

IgA2 immune complexes selectively promote inflammation by human CD103(+) dendritic cells
por: Mes, Lynn, et al.
Publicado: (2023)

Efficacy and safety of zanubrutinib plus R-CHOP in treatment of non-GCB DLBCL with extranodal involvement
por: Geng, Hongzhi, et al.
Publicado: (2023)

Priming Dendritic Cells for Th2 Polarization: Lessons Learned from Helminths and Implications for Metabolic Disorders
por: Hussaarts, Leonie, et al.
Publicado: (2014)

The Hippo Pathway in Innate Anti-microbial Immunity and Anti-tumor Immunity
por: Zhang, Qian, et al.
Publicado: (2020)

T Regulatory Cells and Priming the Suppressive Tumor Microenvironment
por: Paluskievicz, Christina M., et al.
Publicado: (2019)

Strategies to Genetically Modulate Dendritic Cells to Potentiate Anti-Tumor Responses in Hematologic Malignancies
por: Cornel, Annelisa M., et al.
Publicado: (2018)

Creatine supplementation enhances anti-tumor immunity by promoting adenosine triphosphate production in macrophages
por: Peng, Zhenzi, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_8kjnsnjkl87shqpusllbe694bm